REG - Cambridge Cognition - Appointment of Chief Operating Officer
RNS Number : 0989SCambridge Cognition Holdings PLC07 March 20197 March 2019
Cambridge Cognition Holdings Plc
("Cambridge Cognition" or the "Company")
Appointment of Chief Operating Officer
Cambridge Cognition Holdings plc ('the Company'), which develops and markets neuroscience technology to assess brain health, is pleased to announce that Dr. Matthew Stork has agreed to join the Company as Chief Operating Officer on completion of the fundraise announced earlier today.
Matthew has expertise in a broad range of healthcare sectors including healthcare IT, diagnostic imaging, clinical service delivery, capital devices and pharmaceuticals. He has held executive roles at InHealth Group, General Electric, ArjoHuntleigh, Toshiba Medical and Smith and Nephew. It is expected that Matthew will join the Board of Directors of the Company in due course.
Commenting Steven Powell, Chief Executive Officer, said:
"We are delighted to welcome Matthew to Cambridge Cognition - he has extensive experience in digital health and has been successful in driving growth and shareholder value. Matthew will play a key role in driving our penetration of cognitive and clinical assessment markets and to forming strong relationships with corporate partners. Matthew joins us at an exciting time - we have a record level of contracted revenue and substantial demand for our innovative offerings which will provide a platform for growth."
Enquiries:
Cambridge Cognition Holdings plc
Steven Powell, Chief Executive Officer
Tel: 01223 810 700
Nick Walters, Chief Financial Officer
finnCap Ltd (Nomad and Joint Broker)
Tel: 020 7220 0500
Geoff Nash / Simon Hicks
(Corporate Finance)
Alice Lane
(Corporate Broking)
Dowgate Capital Limited (Joint Broker)
Tel: 0203 903 7715
David Poutney / James Serjeant
IFC Advisory Ltd (Financial PR and IR)
Graham Herring / Miles Nolan / Zach Cohen
Tel: 0203 934 6630
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDMSCFMGGFGVNGLZZ
Recent news on Cambridge Cognition Holdings
See all newsREG - Cambridge Cognition - Preliminary Results, Trading Update & Board Change
AnnouncementREG - Cambridge Cognition - Notice of Results
AnnouncementREG - Cambridge Cognition - COG spin-out Monument Therapeutics accesses £1.5m
AnnouncementREG - Cambridge Cognition - Total Voting Rights and Block Listing Return
AnnouncementREG - Cambridge Cognition - Formation of new Scientific Advisory Board
Announcement